Ismo T. Jantunen

5-HT3 receptor antagonists in the prophylaxis of acute vomiting induced by moderately emetogenic chemotherapy—A randomised study

Ismo T. Jantunen, Timo Muhonen, Vesa Kataja et al. · European Journal of Cancer · 1993 · 101 citations

Gastrointestinal Pharmacology, Medicine, Clinical Pharmacology +4

Short- and Long-term Outcome Following Laparoscopic Versus Open Resection for Carcinoma of the Rectum in the Multimodal Setting

Ilmo Kellokumpu, Matti I. Kairaluoma, Kyösti Nuorva et al. · Diseases of the Colon & Rectum · 2012 · 47 citations

Tumour regression grading in the evaluation of tumour response after different preoperative radiotherapy treatments for rectal carcinoma

Jaana Vironen, Martti Juhola, M. Kairaluoma et al. · International Journal of Colorectal Disease · 2005 · 46 citations

Adaptive Radiotherapy, Surgical Oncology, Tumour Response +12

Effects of granisetron with doxorubicin or epirubicin on ECG intervals

Ismo T. Jantunen, Vesa Kataja, Timo Muhonen et al. · Cancer Chemotherapy and Pharmacology · 1996 · 39 citations

Medicine, Physiology, Clinical Pharmacology +5

Prophylactic Filgrastim (G-CSF) During Mitomycin-C, Mitoxantrone, and Methotrexate (MMM) Treatment for Metastatic Breast Cancer

Timo Muhonen, Ismo T. Jantunen, Hannu Pertovaara et al. · American Journal of Clinical Oncology · 1996 · 30 citations